Agilon Health, Inc.

NYSE:AGL

Medical - Care Facilities

Healthcare
$90.53 +2.16%

+$2.26 today

Market cap
$1.52B
Beta
3.04
P/E (TTM)
-4.8
EPS (TTM)
-$22.50
52W Low $7.48High $118.25

Volume 0.79M

Average 0.41M

AGL Total Debt

Short-term and long-term borrowings combined.

Agilon Health, Inc.NYSE: AGL

Total Debt · Q1 FY2026 · quarter ended Mar 2026

Total debt falls 20.5% from a year ago

Total debt stood at $33.4M at the end of Q1 FY2026, down 20.5% from a year earlier and down 9.3% from the prior quarter. Over 3 fiscal years it compounded at -11.2% a year.

Context

  • Total debt amounted to 2.2% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Total debt increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -20.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$33.4M-9.3% QoQ
Last fiscal yearDec 2025
$36.82M-16.3% YoY
Year agoMar 2025
$42.02M-20.5% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.5%——
1 year-16.3%——
3-year CAGR-11.2%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
36.82M USD
Year-over-year change
-16.3%
4-year CAGR
-11.4%

Total Debt vs competitors

How AGL compares with its peers on the latest reported figures

  • AGL's Mar 2026 total debt of $33.4M is the 4th highest of the 10 companies compared; the peer median is $16.3M.
  • Its year-over-year change of -20.5% is the 7th highest of 10, against a peer median of -6.0%.
  • Total debt amounts to 2.2% of total assets for AGL, versus a peer median of 9.7%.
AGL Competitors Peer median
Total Debt for AGL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NAKANakamoto Inc.Mar 2026$209.74M +31373.9%+712.7%33.8%
DHDefinitive Healthcare Corp.Mar 2026$169.84M -6.0%-14.5%33.0%
SOPHSOPHiA GENETICS S.A.Mar 2026$62.43M +107.2%+55.6%39.8%
AGLAgilon Health, Inc.Mar 2026$33.4M -20.5%-11.2%2.2%
ANNXAnnexon, Inc.Mar 2026$25.43M -10.2%-7.3%9.7%
DBVTDBV Technologies S.A.Mar 2026$16.3M +32.0%+73.5%6.1%
ENGNenGene Holdings Inc.Apr 2026$8.25M -67.5%-0.3%2.7%
LRMRLarimar Therapeutics, Inc.Mar 2026$3.78M -22.3%-9.1%1.8%
MCTACharming Medical Limited Class A Ordinary SharesMar 2025$1.16M +20.7%—21.7%
SLPSimulations Plus, Inc.Feb 2026$508K -36.2%-24.0%0.3%
Peer median (excluding AGL) $16.3M-6.0%-3.8%9.7%

Competitors are the stored peer set for AGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.05B465.3M114.33M193.86M173.71M
Short-term Investments0411.9M380.77M211.74M111.43M
Net Receivables293.41M492.36M942.46M1.02B673.79M
Inventory00000
Other Current Assets18.97M81.71M42.51M35.14M137.76M
Total Current Assets1.37B1.45B1.48B1.46B1.1B
Property, Plant & Equipment (Net)20.9M31.95M40.99M36.95M25.42M
Goodwill41.54M2.51M24.13M24.13M0
Intangible Assets55.4M18.45M63.77M72.77M65.73M
Long-term Investments6.69M17.35M44.75M61.76M59.79M
Tax Assets00000
Other Non-current Assets94.53M175.93M87.15M80.6M23.66M
Total Non-current Assets219.06M246.19M260.79M276.21M174.59M
Total Assets1.59B1.7B1.74B1.73B1.27B
Account Payables348.65M478.23M968.06M1.15B1.06B
Short-term Debt8.31M5M9.1M2.46M19.24M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities051.87M000
Total Current Liabilities356.96M535.09M977.16M1.15B1.08B
Long-term Debt43.4M38.48M32.31M34.9M15.75M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities86.39M74.2M59.48M69.52M50.49M
Total Non-current Liabilities137.7M121.77M102.69M111.02M68.07M
Total Liabilities494.66M656.86M1.08B1.26B1.14B
Common Stock4M4.12M4.06M4.12M4.15M
Retained Earnings(957.68M)(1.06B)(1.33B)(1.59B)(1.98B)
Accumulated OCI0(5.56M)(2.3M)(88K)916K
Other Stockholders Equity(0)0000
Minority Interest(300K)(611K)(818K)00
Total Equity1.09B1.04B661.02M470.95M126.73M
Total Debt59.61M52.57M52.31M43.96M36.82M
Net Debt(995.21M)(412.73M)(62.02M)(149.9M)(136.9M)

Agilon Health, Inc.

NYSE:AGL

Intrinsic Alpha fair value

Locked

Current Price

$90.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.